The use of higher-resolution spatial aerial images for semantic segmentation in everyday tasks has increased due to recent advancements in remote sensing and several other applications. Nonetheless, supervised learning necessitates a substantial quantity of images with pixel-level labeling. Currently, available techniques, which are mostly Deep Semantic Segmentation Networks (DSSN), might not be appropriate for application domains with a dearth of labels containing targeted masks of outputs.
View Article and Find Full Text PDFThe increasing prevalence of bacterial pathogens diseases and the rise in multidrug resistance highlights the urgent need for new drug delivery systems or novel drug molecules to enhance treatment options. Zinc oxide (ZnO) nanoparticles attracting attention due to their potential in biomedical applications, such as cancer therapy and diagnostics. ZnO is a versatile compound with excellent UV-blocking, anti-inflammatory, and wide-bandgap semiconductor properties.
View Article and Find Full Text PDFOver the last decade, the environmental and wellness cost of antibiotic drug resistance to the societies have been astounding and require urgent attention Metal oxide nanomaterials have been achieved a pull-on deal with its entire applications in biological and photocatalytic applications. The present study conducts a comparative investigation on chemical and biogenic synthesis of zirconium dioxide (ZrO) nanoparticles aimed at enhancing their efficacy in their applications. The plant extract of Passiflora edulis act as a reducing and capping properties offering a sustainable and eco-friendly alternative.
View Article and Find Full Text PDFBackground: Temporomandibular joint (TMJ) pain is a common condition that can significantly impact an individual's quality of life. Current treatment options often fall short of providing long-lasting relief. So, this prospective clinical study aimed to investigate the efficacy of injectable platelet-rich fibrin (I-PRF) in mitigating TMJ pain.
View Article and Find Full Text PDFBackground: Clinical trials and real world studies demonstrated benefit of mepolizumab treatment in severe asthma but data on its effectiveness beyond 2 years remain limited. Herein, we provide mepolizumab treatment evaluation up to 4 years.
Methods: we studied all patients initiated on mepolizumab in our center from June 2017 to August 2018.